The Journal of Organic Chemistry
4. EXPERIMENTAL SECTION
Article
1
to afford 3b: yellow solid; yield 3.2 g (76%); mp 104−105 °C; H
NMR (400 MHz, CDCl3, ppm) 8.26 (d, J = 2.4 Hz, 1H), 7.67 (s, 1H),
6.93 (dd, J1 = 8.8 Hz, J2 = 2.4 Hz, 1H), 6.81 (d, J = 8.8 Hz, 1H), 3.83
(s, 3H), 3.80 (s, 3H), 2.36 (s, 3H); 13C NMR (100 MHz, CDCl3,
ppm) 167.9, 165.4, 153.9, 153.4, 131.9, 125.3, 122.6, 119.2, 116.5,
111.9, 56.1, 55.8, 15.6; MS (EI, 70 eV) m/z (relative intensity) 247
(M+, 100); HRMS calcd for C13H13O4N 247.0845, found 247.0841.
Anal. Calcd for C13H13O4N: C, 63.15; H, 5.30; N, 5.67. Found: C,
63.01; H, 5.36; N, 5.81.
4.1. Synthesis. The synthetic route of 1d (o-HBDI) has been
described in our previous report and is thus omitted from the
following synthetic elaboration.10
4.2. Physical and Spectroscopic Characterization Data for
Compounds 1a−g, 1h-Z, and 1h-E. 4.2.1. (Z)-4-(2-Methox-
ybenzylidene)-2-phenyloxazol-5(4H)-one (3a). Hippuric acid (5.0 g,
27.9 mmol), sodium acetate (2.3 g, 28.0 mmol), o-anisaldehyde (3.8 g,
27.9 mmol), and acetic anhydride (50 mL) were heated at 80 °C with
stirring for 4 h. After the solvent was removed, the crude product was
purified by silica gel column chromatography with ethyl acetate/n-
hexane (1/2) as eluent to afford 3a: yellow solid; yield 5.5 g (71%);
mp 110−111 °C; 1H NMR (400 MHz, CD2Cl2, ppm) 8.89 (d, J = 8.8
Hz, 1H), 8.20−8.17 (m, 2H), 7.82 (s, 1H), 7.66 (t, J = 7.4 Hz, 1H),
7.58 (m, 2H), 7.48 (t, J = 8.6 Hz, 1H), 7.13 (t, J = 7.6 Hz, 1H), 6.99
(d, J = 8.4 Hz, 1H), 3.95 (s, 3H); 13C NMR (100 MHz, CD2Cl2, ppm)
167.5, 163.1, 159.3, 133.1, 132.9, 132.7, 132.5, 128.9, 128.1, 125.8,
125.3, 122.5, 120.8, 110.8, 55.7; MS (EI, 70 eV) m/z (relative
intensity) 279 (M+, 100); HRMS calcd for C17H13O3N 279.0895,
found 279.0891. Anal. Calcd for C17H13O3N: C, 73.11; H, 4.69; N,
5.02. Found: C, 73.37; H, 4.75; N, 5.22.
4.2.2. (Z)-4-(2-Methoxybenzylidene)-1-methyl-2-phenyl-1H-imi-
dazol-5(4H)-one (2a). (Z)-4-(2-Methoxybenzylidene)-2-phenyloxa-
zol-5(4H)-one (3a; 1.0 g, 3.6 mmol) was added to potassium
carbonate (0.5 g, 3.6 mmol) in a 50 mL round-bottom flask, in which
20 mL of ethanol (95%) and 1.0 mL of methylamine (40% aqueous)
were then added. The reaction mixture was refluxed for 4 h. After
cooling, the mixture was neutralized with 10% HCl and extracted with
CH2Cl2 (3 × 25 mL). After solvent was removed, the crude product
was purified by silica gel column chromatography with ethyl acetate/n-
hexane (1/2) as eluent to afford 2a: yellow solid; yield 0.7 g (67%);
mp 126−127 °C; 1H NMR (400 MHz, CDCl3, ppm) 8.92 (d, J = 7.6
Hz, 1H), 7.85−7.83 (m, 3H), 7.56−7.52 (m, 3H), 7.37 (t, J = 8.4 Hz,
1H), 7.04 (t, J = 7.6 Hz, 1H), 6.91 (d, J = 8.3 Hz, 1H), 3.90 (s, 3H),
3.37 (s, 3H); 13C NMR (100 MHz, CDCl3, ppm) 171.7, 161.8, 159.3,
138.4, 133.3, 131.9, 131.3, 129.5, 128.7, 128.6, 123.4, 122.9, 120.9,
110.5, 55.5, 29.0; MS (EI, 70 eV) m/z (relative intensity) 292 (M+,
100); HRMS calcd for C18H16O2N2 292.1212, found 292.1219. Anal.
Calcd for C18H16O2N2: C, 73.95; H, 5.52; N, 9.58. Found: C, 73.69;
H, 5.56; N, 9.80.
4.2.3. (Z)-4-(2-Hydroxybenzylidene)-1-methyl-2-phenyl-1H-imi-
dazol-5(4H)-one (1a). (Z)-4-(2-Methoxybenzylidene)-1-methyl-2-
phenyl-1H-imidazol-5(4H)-one (2a; 300 mg, 1.0 mmol) was dissolved
in 10 mL of dichloromethane in a 50 mL round-bottom flask, and the
flask was placed in an ice bath at 0 °C. A solution of boron tribromide
(4.0 mL, 1.0 M solution in dichloromethane) was added carefully to
the stirred solution under a nitrogen atmosphere. After 4 h, the
reaction mixture was cooled and then hydrolyzed by careful shaking
with 10 mL of water and extracted twice with 10 mL of
dichloromethane. The combined organic phases were then dried
over magnesium sulfate, filtered, and evaporated in vacuo, and the
crude product was purified by silica gel column chromatography with
ethyl acetate/n-hexane (1/2) as eluent to afford 1a: yellow solid; yield
265 mg (94%); mp 150−151 °C; 1H NMR (400 MHz, CD2Cl2, ppm)
13.94 (s, 1H), 7.84−7.81 (m, 2H), 7.66−7.57 (m, 3H), 7.38−7.35 (m,
2H), 7.28 (s, 1H), 6.94 (d, J = 8.5 Hz, 1H), 6.88 (t, J = 7.4 Hz, 1H),
3.39 (s, 3H); 13C NMR (100 MHz, CD2Cl2, ppm) 168.5, 158.7, 157.6,
136.4, 134.2, 133.3, 132.0, 130.7, 129.0, 128.3, 127.8, 119.9, 119.3,
119.0, 29.1; MS (EI, 70 eV) m/z (relative intensity) 278 (M+, 100);
HRMS calcd for C17H14O2N2 278.1055, found 278.1049. Anal. Calcd
for C17H14O2N2: C, 73.37; H, 5.07; N, 10.07. Found: C, 73.21; H,
5.11; N, 10.29. Yellow needle-shaped crystals suitable for the
crystallographic studies reported here were isolated over a period of
6 weeks by slow evaporation from the chloroform solution.
4.2.5. (Z)-4-(2,5-Dimethoxybenzylidene)-1,2-dimethyl-1H-imida-
zol-5(4H)-one (2b). (Z)-4-(2,5-Dimethoxybenzylidene)-2-methyloxa-
zol-5(4H)-one (3b; 1.2 g, 4.8 mmol) was added to potassium
carbonate (0.7 g, 5.1 mmol) in a 50 mL round-bottom flask, in which
15 mL of ethanol (95%) and 1.0 mL of methylamine (40% aqueous)
were then added. The reaction mixture was refluxed for 4 h. After
cooling, the mixture was neutralized with 10% HCl and extracted with
CH2Cl2 (3 × 25 mL). After solvent was removed, the crude product
was purified by silica gel column chromatography with ethyl acetate/n-
hexane (1/1) as eluent to afford 2b: yellow solid; yield 0.81 g (65%);
mp 118−119 °C; 1H NMR (400 MHz, CDCl3, ppm) 8.39 (d, J = 3.0
Hz, 1H), 7.58 (s, 1H), 6.87 (dd, J1 = 9.0 Hz, J2 = 3.0 Hz, 1H), 6.78 (d,
J = 9.1 Hz, 1H), 3.79 (s, 3H), 3.77 (s, 3H), 3.12 (s, 3H), 2.29 (s, 3H);
13C NMR (100 MHz, CDCl3, ppm) 170.6, 161.9, 153.8, 153.4, 138.3,
123.6, 120.8, 117.8, 117.0, 111.7, 56.1, 55.7, 26.4, 15.6; MS (EI, 70 eV)
m/z (relative intensity) 260 (M+, 54), 229 (100); HRMS calcd for
C14H16O3N2 260.1161, found 260.1156. Anal. Calcd for C14H16O3N2:
C, 64.60; H, 6.20; N, 10.76. Found: C, 64.42; H, 6.26; N, 10.92.
4.2.6. (Z)-4-(2-Hydroxy-5-methoxybenzylidene)-1,2-dimethyl-1H-
imidazol-5(4H)-one (1b). (Z)-4-(2,5-Dimethoxybenzylidene)-1,2-di-
methyl-1H-imidazol-5(4H)-one (2b; 286 mg, 1.1 mmol) was dissolved
in 10 mL of dichloromethane in a 50 mL round-bottom flask, and the
flask was placed in an ice bath at 0 °C. A solution of boron tribromide
(4.4 mL, 1.0 M solution in dichloromethane) was added carefully to
the stirred solution under a nitrogen atmosphere. After 4 h, the
reaction mixture was cooled and then hydrolyzed by careful shaking
with 10 mL of water and extracted twice with 10 mL of
dichloromethane. The combined organic phases were then dried
over magnesium sulfate, filtered, and evaporated in vacuo, and the
crude product was purified by silica gel column chromatography with
ethyl acetate/n-hexane (1/1) as eluent to afford 1b: yellow solid; yield
241 mg (89%); mp 146−147 °C; 1H NMR (400 MHz, CD2Cl2, ppm)
13.26 (s, 1H), 7.09 (s, 1H), 6.97 (dd, J1 = 8.9 Hz, J2 = 3.0 Hz, 1H),
6.88 (d, J = 8.9 Hz, 1H), 6.76 (d, J = 3.0 Hz, 1H), 3.76 (s, 3H), 3.20
(s, 3H), 2.36 (s, 3H); 13C NMR (100 MHz, CD2Cl2, ppm) 167.9,
157.7, 152.8, 152.2, 133.2, 129.8, 121.7, 120.0, 119.4, 118.3, 55.7, 26.7,
15.1; MS (EI, 70 eV) m/z (relative intensity) 246 (M+, 100); HRMS
calcd for C13H14O3N2 246.1004, found 246.1008. Anal. Calcd for
C13H14O3N2: C, 63.40; H, 5.73; N, 11.38. Found: C, 63.26; H, 5.77;
N, 11.56. Yellow needle-shaped crystals suitable for the crystallo-
graphic studies reported here were isolated over a period of 5 weeks by
slow evaporation from the chloroform solution.
4.2.7. (Z)-4-(5-Bromo-2-methoxybenzylidene)-2-methyloxazol-
5(4H)-one (3c). N-Acetylglycine (2.0 g, 17.1 mmol), sodium acetate
(1.4 g, 17.1 mmol), 5-bromo-2-methoxybenzaldehyde (3.6 g, 16.7
mmol), and acetic anhydride (40 mL) were heated at 80 °C with
stirring for 4 h. After solvent was removed, the crude product was
purified by silica gel column chromatography with ethyl acetate/n-
hexane (1/2) as eluent to afford 3c: yellow solid; yield 3.6 g (71%);
mp 145−146 °C; 1H NMR (400 MHz, CDCl3, ppm) 8.75 (d, J = 1.7
Hz, 1H), 7.57 (s, 1H), 7.46 (dd, J1 = 8.4 Hz, J2 = 1.7 Hz, 1H), 6.78 (d,
J = 8.8 Hz, 1H), 3.86 (s, 3H), 2.39 (s, 3H); 13C NMR (100 MHz,
CDCl3, ppm) 167.6, 166.3, 158.0, 135.0, 134.7, 132.7, 124.0, 123.5,
113.3, 112.4, 55.9, 15.6; MS (EI, 70 eV) m/z (relative intensity) 295
(M+, 70), 225 (100); HRMS calcd for C12H10BrO3N 294.9844, found
294.9848. Anal. Calcd for C12H10O3NBr: C, 48.67; H, 3.40; N, 4.73.
Found: C, 48.49; H, 3.42; N, 4.87.
4.2.4. (Z)-4-(2,5-Dimethoxybenzylidene)-2-methyloxazol-5(4H)-
one (3b). N-Acetylglycine (2.0 g, 17.1 mmol), sodium acetate (1.4
g, 17.1 mmol), 2,5-dimethoxybenzaldehyde (2.8 g, 16.8 mmol), and
acetic anhydride (40 mL) were heated at 80 °C with stirring for 4 h.
After solvent was removed, the crude product was purified by silica gel
column chromatography with ethyl acetate/n-hexane (1/2) as eluent
4.2.8. (Z)-4-(5-Bromo-2-methoxybenzylidene)-1,2-dimethyl-1H-
imidazol-5(4H)-one (2c). (Z)-4-(5-Bromo-2-methoxybenzylidene)-2-
methyloxazol-5(4H)-one (3c; 1.3 g, 4.4 mmol) was added to
potassium carbonate (0.7 g, 5.1 mmol) in a 50 mL round-bottom
8198
dx.doi.org/10.1021/jo2012384|J. Org. Chem. 2011, 76, 8189−8202